The Artificial Pancreas Question: An Exploration of Existing and Emerging Technology

POSTER

The Artificial Pancreas Question: An Exploration of Existing and Emerging Technology James Murray, BSN, DNP-Student, Margaret F. Clayton, PhD, FNP-BC, FAAN, and Michelle Litchman, PhD, FNP-BC Key Findings: Most prevalent barrier to answering patient questions was not knowing how “Do-it-yourself” systems work (74.4%). Majority of phase 1 participants indicated they are open to multiple forms of education on open source APS systems (91%). After reviewing the fact sheet, 70% of phase 2 participants stated that they were either comfortable or very comfortable discussing open source APS systems with patients. Background Results • T1D Prevalence: 1.3 to 1.5 million • 74.4% phase 1 participants said their greatest barrier answering patient questions about “Do-it-yourself APS systems” was not knowing how the systems work • Estimated U.S. lifetime T1Ds’ cost: $281.2 billion • Technology offers hope for better management • 91% of phase 1 participants said they are open to multiple education forms on open source APS systems • Barriers to APS technology include access, long FDA approval process, & lack of user input on APS design • 70% of phase 2 participants stated they were comfortable or very comfortable discussing open source APS systems with patients after reviewing fact sheet • Creation of easily accessible comparison APS info is needed for CDEs to answer patient questions fully Methods Theoretical Framework: The Diffusion of Innovation guided the study to inform uptake of APS systems Phase 1 • Assessed participants regarding perceived need for fact sheet at the Sandy, UT AADE conference in November, 2018 (n=43) • 2-sided fact sheet developed for review by diabetes educators Phase 2 • Fact sheet explanation/submission to Intermountain Pediatric Diabetes and Endocrinology medical group and online CDE community for review • Post-Survey diabetes educators’ perceived usefulness of white paper/fact sheet (n=12) Most prevalent barrier to answering patient questions was not knowing how “Do-it-yourself” systems work (74.4%) After seeing fact sheet, 70% participants stated they were comfortable discussing open-source options with patients Conclusions • There is a need for more information on APS systems • The fact sheet we developed was deemed useful • We discovered need for flexible educational approaches • Fitting with the Diffusion of Innovation theoretical framework, patients are early adopters, which creates a disconnect with later adopter providers • Increased awareness of APS systems among care providers can improve quality of life and safety for patients • Increased awareness and uptake of APS technology offer hope to further reduce the burden of diabetes COLLEGE OF NURSING